Head to head

NMN vs NR: which NAD+ booster has better evidence?

Last reviewed 22 August 2026 · grades regenerate automatically when the evidence changes

This is the most-asked head-to-head in the supplement aisle, and the honest answer disappoints both camps: the two NAD+ precursors are more alike in their evidence than their marketing suggests. Both reliably raise blood NAD+. Neither has shown that raising it does anything you would notice — and neither has any lifespan evidence at all.

Nicotinamide mononucleotide (NMN)

Insufficient long-term safety data

Human trials indicate NMN raises blood NAD+ and is generally well tolerated over the periods studied. Evidence that this translates into meaningful health benefits is early and inconsistent, and no human study has examined lifespan.

EarlySurrogate biomarker
Raises NAD+ levels in blood
InsufficientLifespan
Extends human lifespan
InsufficientSurrogate biomarker
Improves blood pressure

Full evidence page →

Nicotinamide riboside (NR)

Generally well tolerated in studies

Human trials support that NR raises NAD+ and is tolerated. Trials in specific conditions have produced mixed results, and no human lifespan evidence exists.

EarlyDisease outcome
Improves outcomes in specific diagnosed conditions
InsufficientLifespan
Extends human lifespan

Full evidence page →

The honest verdict

If the question is 'which one raises NAD+', both do, and choosing between them on that basis is choosing between two receipts for the same purchase. If the question is 'which one has shown a health benefit in people', neither has cleared that bar in replicated trials.

The genuinely useful comparison is not NMN versus NR but either-of-them versus not-buying: the claims grid below shows where each stands on the questions that matter, and 'insufficient' appears in the rows the marketing is built on.

Sources

Every study behind both columns, each verified against PubMed at build time.

Keep reading

Best longevity supplements UK →Why our grades change →Grade your own stack →

Educational information, not medical advice. Grades are produced by our published methodology from recorded study facts; prescription decisions belong with a clinician.